Intuitive Surgical Inc ISRG Stock Analysis
- Nasdaq
- Stock
- Market closed · opens Monday 9:30 AM ET
$452.80 down $15.72, 3.36% at close Nov 6
Last close · Previous close $468.52
- Market cap
- At the Nov 6 close
- P/E ratio
- 54.82On last 12 months’ EPS
- Diluted EPS
- $8.26Last 12 months
- Dividend yield
- NoneLast 12 months
Price chart
$452.80down $15.72, 3.36%Fri, Nov 6 session
Use the left and right arrow keys to move along the chart.
Price data
Trading
- Previous close$468.52Nov 5
- Volume2.15MNov 6 session
Shares traded on all US exchanges in the last completed session. Live intraday volume covers IEX only, so it is left out.
- Avg. volume2.74MLast 21 sessions
The average daily shares traded over the last 21 trading sessions, about one calendar month.
- 52-week range: $328.57 to $603.88; now $452.80
The lowest and highest trades over the past 52 weeks, adjusted for splits. The marker shows the latest price.
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
Performance
Past performance, measured to the Nov 6 close. Total return includes reinvested dividends.Price change only, without dividends. Compared with the S&P 500, using SPY.
ISRG beat the S&P 500 in 3 of 7 periods.
| Period | ISRG and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | ISRG: up 11.9% S&P 500: down 5.6% | ISRG beat the S&P 500 by 17.5 percentage points Beat |
| 3M | ISRG: up 21.2% S&P 500: down 4.1% | ISRG beat the S&P 500 by 25.3 percentage points Beat |
| YTD | ISRG: down 20.1% S&P 500: up 8.7% | ISRG trailed the S&P 500 by 28.8 percentage points Trailed |
| 1Y | ISRG: down 17.3% S&P 500: up 10.9% | ISRG trailed the S&P 500 by 28.2 percentage points Trailed |
| Long term | ||
| 3Y | ISRG: up 63.3% S&P 500: up 75.0% +17.8% vs +20.5% a year | ISRG trailed the S&P 500 by 11.7 percentage points Trailed |
| 5Y | ISRG: up 24.1% S&P 500: up 67.8% +4.4% vs +10.9% a year | ISRG trailed the S&P 500 by 43.7 percentage points Trailed |
| 10Y | ISRG: up 507.0% S&P 500: up 313.1% +19.8% vs +15.2% a year | ISRG beat the S&P 500 by 193.9 percentage points Beat |
$10,000 invested in ISRG 10 years ago (Nov 4, 2016) would be worth about $60,695 at the close on , with dividends reinvested. The same amount in the S&P 500 would be worth about $41,313.
ISRG beat the S&P 500 in 3 of 7 periods.
| Period | ISRG and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | ISRG: up 11.9% S&P 500: down 5.6% | ISRG beat the S&P 500 by 17.5 percentage points Beat |
| 3M | ISRG: up 21.2% S&P 500: down 4.3% | ISRG beat the S&P 500 by 25.5 percentage points Beat |
| YTD | ISRG: down 20.1% S&P 500: up 7.8% | ISRG trailed the S&P 500 by 27.9 percentage points Trailed |
| 1Y | ISRG: down 17.3% S&P 500: up 9.7% | ISRG trailed the S&P 500 by 27.0 percentage points Trailed |
| Long term | ||
| 3Y | ISRG: up 63.3% S&P 500: up 68.8% +17.8% vs +19.1% a year | ISRG trailed the S&P 500 by 5.5 percentage points Trailed |
| 5Y | ISRG: up 24.1% S&P 500: up 56.9% +4.4% vs +9.4% a year | ISRG trailed the S&P 500 by 32.8 percentage points Trailed |
| 10Y | ISRG: up 507.0% S&P 500: up 252.6% +19.8% vs +13.4% a year | ISRG beat the S&P 500 by 254.4 percentage points Beat |
$10,000 invested in ISRG 10 years ago (Nov 4, 2016) would be worth about $60,695 at the close on , not counting dividends. The same amount in the S&P 500 would be worth about $35,257.
All-time high
$610.45
Closing high on . Now 25.8% below that record.
Split-adjusted daily closes since Jun 16, 2000.
Stock splits
3
Latest: 3-for-1 on . One share bought before the first split is 5 shares today.
All 3 splits
- 3-for-1
- 3-for-1
- 1-for-2
Valuation
Financials
Reported results, not forecasts. From company filings via Tiingo; the latest report is Q3 FY26, the quarter ended Sep 30, 2026. “Last 12 months” means the four quarters from Oct 1, 2025 to Sep 30, 2026, and balance-sheet figures are as of Sep 30, 2026.
Revenue and net income
Last 12 months, with the change from the 12 months before
- Revenue
- $11.58Bup 20.5%
- Net income
- $2.96Bup 7.7%
- Diluted EPS
- $8.26up 9.1%
Data table
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| Q4 FY24 (Dec 31, 2024) | $2.41B | $685.70M | $1.89 |
| Q1 FY25 (Mar 31, 2025) | $2.25B | $698.40M | $1.92 |
| Q2 FY25 (Jun 30, 2025) | $2.44B | $658.40M | $1.81 |
| Q3 FY25 (Sep 30, 2025) | $2.51B | $704.40M | $1.95 |
| Q4 FY25 (Dec 31, 2025) | $2.87B | $794.80M | $2.20 |
| Q1 FY26 (Mar 31, 2026) | $2.77B | $821.50M | $2.28 |
| Q2 FY26 (Jun 30, 2026) | $2.89B | $818.10M | $2.29 |
| Q3 FY26 (Sep 30, 2026) | $3.05B | $522.80M | $1.49 |
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| FY21 (Dec 31, 2021) | $5.71B | $1.70B | $4.66 |
| FY22 (Dec 31, 2022) | $6.22B | $1.32B | $3.65 |
| FY23 (Dec 31, 2023) | $7.12B | $1.80B | $5.03 |
| FY24 (Dec 31, 2024) | $8.35B | $2.32B | $6.42 |
| FY25 (Dec 31, 2025) | $10.06B | $2.86B | $7.87 |
Margins
- Gross 67.2%
- Operating 28.4%
- Net 25.5%
The percentages above the chart cover the last 12 months; the lines show each quarter. What margins tell you
Cash flow
- $3.64BLast 12 months
Cash from operations minus capital spending: the cash left after the business maintains and grows its assets.
FCF = Operating cash flow − Capital spendingFree cash flow - Operating cash flow$4.09BLast 12 months
- Capital spending$445.50MLast 12 months
- 31.5%Last 12 months
Free cash flow as a share of revenue, both over the last 12 months.
Shareholder returns
- $4.26BLast 12 months
Cash spent repurchasing shares, net of shares issued. Buybacks shrink the share count, so each remaining share owns more of the company.
- Dividends paid$0.00Last 12 months
- Total returned$4.26BLast 12 months
117% of free cash flow
Balance sheet
- $6.80BAs of Sep 30, 2026
Cash plus short- and long-term marketable securities on the Sep 30, 2026 balance sheet.
- Total debt$0.00As of Sep 30, 2026
- Net cash$6.80BAs of Sep 30, 2026
- 3.33As of Sep 30, 2026
Current assets divided by current liabilities on the Sep 30, 2026 balance sheet. Above 1 means short-term assets cover the bills due within a year.
Current ratio = Current assets ÷ Current liabilitiesCurrent ratio - 0.00As of Sep 30, 2026
Total debt divided by shareholders’ equity on the Sep 30, 2026 balance sheet: a measure of financial leverage.
D/E = Total debt ÷ Shareholders’ equityDebt-to-equity ratio
Financial strength
- 7 of 9Last 12 months
vs the 12 beforeA 0–9 checklist from accounting professor Joseph Piotroski. Each test compares the last 12 months with the 12 months before and scores a point if it passes. 8–9 is strong; 0–2 is weak.
- ✓Net income was positive: passed
- ✓Operating cash flow was positive: passed
- ✗Return on assets improved: not passed
- ✓Operating cash flow exceeded net income: passed
- ✓Long-term debt fell relative to assets: passed
- ✗Current ratio improved: not passed
- ✓Share count didn’t rise: passed
- ✓Gross margin improved: passed
- ✓Asset turnover (revenue ÷ assets) improved: passed
- 17.0%Last 12 months
Over the last 12 months, Intuitive Surgical’s net income was 17.0% of its shareholders’ equity (averaged over the last four quarter-ends). It describes the past year, not an expected return.
ROE = Net income (last 12 months) ÷ Average equityReturn on equity - 14.6%Last 12 months
Over the last 12 months, Intuitive Surgical’s net income was 14.6% of its total assets (averaged over the last four quarter-ends): what the business earned on everything it owns.
ROA = Net income (last 12 months) ÷ Average total assets
About Intuitive Surgical Inc
Intuitive, headquartered in Sunnyvale, California, is a global leader in minimally invasive care and the pioneer of robotic surgery. Our technologies include the da Vinci surgical system and the Ion endoluminal system. By uniting advanced systems, progressive learning, and value-enhancing services, we help physicians and their teams optimize care delivery to support the best outcomes possible. At Intuitive, we envision a future of care that is less invasive and profoundly better, where disease is identified early and treated quickly, so that patients can get back to what matters most. About da Vinci Surgical Systems There are several models of the da Vinci Surgical System. The da Vinci surgical systems are designed to help surgeons perform minimally invasive surgery and offer surgeons high-definition 3D vision, a magnified view, and robotic and computer assistance. They use specialized instrumentation, including a miniaturized surgical camera and wristed instruments (i.e., scissors, scalpels, and forceps) that are designed to help with precise dissection and reconstruction deep inside the body. About the Ion Endoluminal System The Ion Endoluminal System (Model IF1000) assists the user in navigating a catheter and endoscopic tools in the pulmonary tract using endoscopic visualization of the tracheobronchial tree for diagnostic and therapeutic procedures. The Ion Endoluminal System enables fiducial marker placement. It does not make a diagnosis and is not for pediatric use. Information provided by the Ion Endoluminal System or its components should be considered guidance only and not replace clinical decisions made by a trained physician.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Headquarters
- California, USA
- SEC filings
- EDGAR (opens in a new tab)
- Exchange
- Nasdaq
- Asset type
- Common stock
- Price history since
ISRG news
Explore more stocks
Prices are from the last refresh. Open any stock for its live dashboard.
Popular stocks
ISRG stock FAQ
What is ISRG stock’s price today?
Intuitive Surgical (ISRG) traded at $452.80 at the close on , down $15.72 (3.36%) from the previous close of $468.52. Over the past 52 weeks it has traded between $328.57 and $603.88.
If you invested $1,000 in ISRG 10 years ago, how much would you have now?
With dividends reinvested, $1,000 invested in ISRG on would be worth about $6,070 at the close on , a total return of +507.0%. The same $1,000 would be worth $1,241 if invested five years ago, $827 if invested one year ago, and $40,813 if invested 20 years ago. Past performance doesn’t predict future returns.
What is ISRG’s P/E ratio?
ISRG trades at 54.8 times its diluted earnings over the four quarters to ($8.26 per share), at the close. (How the P/E ratio works.)
How much revenue does Intuitive Surgical make?
Intuitive Surgical reported $11.6 billion of revenue over the four quarters to , up 20.5% from the twelve months before. In its latest quarter (Q3 FY26, ended ) revenue was $3.0 billion, up 21.7% from a year earlier.
Is Intuitive Surgical profitable?
Yes. Intuitive Surgical earned $3.0 billion of net income over the four quarters to , a net margin of 25.5%, and its operating margin was 28.4% (what margins tell you).
What are ISRG’s earnings per share?
ISRG’s diluted earnings per share were $8.26 over the four quarters to , compared with $7.57 in the twelve months before. The latest quarter (Q3 FY26) brought $1.49 per share, against $1.95 a year earlier (how EPS works).
Does ISRG pay a dividend?
Intuitive Surgical hasn’t paid a dividend in the last twelve months.
What is ISRG’s 52-week high and low?
Over the past 52 weeks ISRG has traded as low as $328.57 and as high as $603.88. At $452.80 at the close on , it is 25.0% below that high and 37.8% above the low.
What is ISRG’s all-time high?
ISRG’s highest closing price was $610.45 on , adjusted for stock splits. At $452.80 at the close on , it is 25.8% below that record.
Has ISRG stock ever split?
Yes, three times: 1-for-2 on ; 3-for-1 on ; 3-for-1 on . One share bought before the first split would be 5 shares today.
How has ISRG stock performed?
Including dividends and measured to the close on , ISRG has returned −20.1% so far this year and −17.3% over the past year, and +24.1% over five years (+4.4% a year). Over the same periods the S&P 500, measured by SPY, returned +8.7%, +10.9% and +67.8%. Past performance doesn’t predict future returns.
What sector and industry is Intuitive Surgical in?
Intuitive Surgical is in the Healthcare sector and the Medical Instruments & Supplies industry, and is headquartered in California, USA.
What exchange does ISRG trade on?
Intuitive Surgical trades on the Nasdaq under the ticker symbol ISRG. Its price history on this dashboard begins on .
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.
This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).
The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.